Leaving previously implanted central venous catheters (ports) in place does not increase morbidity in patients undergoing autologous peripheral stem cell transplantation

Bone Marrow Transplantation

Volumn 36, Issue 2, 2005, Pages 131-134

  Miceli, Marisa H ^a   Dong, L ^a   Coria, P ^b   Vila, A ^c   Estrada, S ^b   Garcia Damiano, M C ^b   Martinez Rolon J ^b   Milone, G ^b   Dignani, M C ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Fundacion para Combatir La Leucemia   (Argentina)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Infections; Ports; Transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUSULFAN; CARBOPLATIN; CEFEPIME; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUCONAZOLE; IFOSFAMIDE; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VALACICLOVIR; VANCOMYCIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANDIDA; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DEATH; DEVICE REMOVAL; DISEASE DURATION; DRUG UTILIZATION; FEVER; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HODGKIN DISEASE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MORBIDITY; MULTIPLE MYELOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEPSIS; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS;

ADULT; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; VANCOMYCIN;

EID: 22744431889     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705018     Document Type: Review

References (13)

1. Gyves J, Ensminger W, Niederhuber J et al. Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med 1982; 73: 841-845.
2. Niederhuber JE, Ensminger W, Gyves JW et al. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982; 92: 706-712.
3. Biffi R, de Braud F, Orsi F et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 1998; 9: 767-773.
4. Chang L, Tsai JS, Huang SJ, Shih CC. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 2003; 31: 34-39.
5. Huang WT, Chen TY, Su WC et al. Implantable venous port-related infections in cancer patients. Support Care Cancer 2004; 12: 197-201.
6. Douard MC, Arlet G, Longuet P et al. Diagnosis of venous access port-related infections. Clin Infect Dis 1999; 29: 1197-1202.
7. Murray PR, Baron EJ. MAP Manual of Clinical Microbiology, 7th ed. American Society of Microbiology Press: Washington, DC, 1999.
8. Andremont A, Paulet R, Nitenberg G, Hill C. Value of semiquantitative cultures of blood drawn through catheter hubs for estimating the risk of catheter tip colonization in cancer patients. J Clin Microbiol 1988; 26: 2297-2299.
9. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2002; 30: 476-489.
10. Linares J, Sitges-Serra A, Garau J et al. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985; 21: 357-360.
11. Brun-Buisson C, Abrouk F, Legrand P et al. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-977.
12. Raad I, Costerton W, Sabharwal U et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168: 400-407.
13. Carey PJ. Drug-induced myelosuppression: diagnosis and management. Drug Saf 2003; 26: 691-706.